Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| (R)-(+)-Camphor | (+)-2-Bornanone; (+)-Camphor; (1R)-(+)-Camphor; (1R)-Camphor; (1R,4R)-(+)-Camphor; (1R,4R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one; (R)-(+)-Camphor; (R)-Camphor; Alcanfor; Camphor, (+)-; D-(+)-Camphor; d-Camphor; | 464-49-3 | C10H16O | 152.23 | (+)-2-Bornanone; (+)-Camphor; (1R)-(+)-Camphor; (1R)-Camphor; (1R,4R)-(+)-Camphor; (1R,4R)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one; (R)-(+)-Camphor;... |
| 23-Keto O-Trimethylsilyl Nemadectin | (6R,25S)-5-O-Demethyl-28-deoxy-25-[(1E)-1,3-dimethyl-1-buten-1-yl]-5-O-[(1,1-dimethylethyl)dimethylsilyl]-6,28-epoxy-23-oxomilbemycin B; [6R,25S(E)]-B, 5-O-Demethyl-28-deoxy-25-(1,3-dimethyl-1-butenyl)-5-O-[(1,1-dimethylethyl)dimethylsilyl]-6,28-epoxy-23-oxo-milbemycin; Spiro[11,15-methano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadecin-13,2’-[2H]pyran] Milbemycin B Derviative | 112125-06-1 | C42H64O8Si | 725.04 | (6R,25S)-5-O-Demethyl-28-deoxy-25-[(1E)-1,3-dimethyl-1-buten-1-yl]-5-O-[(1,1-dimethylethyl)dimethylsilyl]-6,28-epoxy-23-oxomilbemycin B; [6R,25S(E)]-B... |
| 11-Keto Oxcarbazepine | 10,11-Dihydro-10,11-dioxo Carbamazepine; 10,11-Dihydro-10,11-dioxo-5H-dibenz[b,f]azepine-5-carboxamide; | 537693-29-1 | C15H10N2O3 | 266.25 | 10,11-Dihydro-10,11-dioxo Carbamazepine; 10,11-Dihydro-10,11-dioxo-5H-dibenz[b,f]azepine-5-carboxamide;
|
| 3-Keto Petromyzonol | (5α,7α,12α)-7,12,24-Trihydroxycholan-3-one; 3-Ketopetromyzonol; | 359436-56-9 | C24H40O4 | 392.58 | (5α,7α,12α)-7,12,24-Trihydroxycholan-3-one; 3-Ketopetromyzonol;
|
| 2-Chloromethyl Dabigatran Etexilate | Ethyl 3-(2-(((chloromethyl)(4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-indole-5-carboxamido)propanoate; Dabigatran Etexiliate Impurity I; | NA | C35H42ClN7O5 | 676.2 | Ethyl 3-(2-(((chloromethyl)(4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-indole-5-carboxamido)propanoate; ... |
| Chemical Name:Â 2-Ethylbutyl Chloroformate | Carbonochloridic Acid 2-Ethylbutyl Ester | 58906-64-2 | C7H13ClO2 | 164.63 | Carbonochloridic Acid 2-Ethylbutyl Ester
|
| 2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylic Acid Ethyl Ester Hydrochloride | 2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylic Acid Ethyl Ester Hydrochloride is derived from Dabigatran (D100090), which is a non-peptide, direct thrombin inhibior and anti-thrombotic. | 1422435-39-9 | C19H21N5O2 • (HCl) | 351.403646 | 2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylic Acid Ethyl Ester Hydrochloride is derived from Dabigatran (D10009... |
| 2-[[[4-[(Z)-Amino[[(hexyloxy)carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylic Acid | Dabigatran Impurity | 1848337-06-3 | C24H29N5O4 | 451.52 | Dabigatran Impurity
|
| 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (1.0 mg/mL in Acetonitrile) | 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; NNK; | 64091-91-4 | C10H13N3O2 | 207.23 | 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone; NNK;
|
| rac N’-Nitrosonornicotine-d4 (1.0 mg/mL in Acetonitrile) | NNN-D4; (+/-)-5-(1-Nitroso-2-pyrrolidinyl)pyridine-2,3,4,6-d4; | 66148-19-4 | C9H7D4N3O | 181.23 | NNN-D4; (+/-)-5-(1-Nitroso-2-pyrrolidinyl)pyridine-2,3,4,6-d4;
|
Page 589 of 10017